ArticleLeukemia2008

Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia.

J E Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.